Flanders, NJ, United States of America

Sidney Roemer

This inventor holds 3 USPTO granted patents. Top assignee: Warner-Lambert Company. Active years: 1977-1980.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sidney Roemer. Retrieved from https://idiyas.com/inventor/sidney-roemer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 1977-1980

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sidney Roemer

Introduction

Sidney Roemer is a notable inventor based in Flanders, NJ (US), recognized for his significant contributions to the field of antibiotics. With a total of 3 patents, Roemer has made strides in developing compounds that have potential applications in medical treatments.

Latest Patents

Roemer's latest patents focus on diacyloxyacids derived from an antibiotic substance known as acid S, produced by Polyangium cellulosum var. fulvum (ATCC No. 25532). These diacyloxyacids are highlighted for their usefulness as antifungal and antibacterial agents. The processes for their production are also detailed in his patents, showcasing the innovative methods he has developed.

Career Highlights

Throughout his career, Roemer has been associated with the Warner-Lambert Company, where he has contributed to various research initiatives. His work has been instrumental in advancing the understanding and application of antibiotic substances.

Collaborations

Roemer has collaborated with notable colleagues, including David T. Connor and Samuel M. Ringel, who have played a role in his research endeavors.

Conclusion

Sidney Roemer's innovative work in the field of antibiotics, particularly through his patents on diacyloxyacids, underscores his importance as an inventor. His contributions continue to influence the development of effective medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…